University of Southern California (USC) scientists havemade an advancement in chimeric antigen receptor (CAR) T-cell therapy that seems to eliminate its severe side effects, making the treatment safer and potentially available in outpatient

RocheGets Ventana in the End Roche went through a lot (and we do mean a lot) to acquire Ventana Medical Systems. The Basel, Switzerland-based company made offers and even tried a hostile takeover attempt to pick up the molecular diagnostics

Hologic Shines With Gen-Probe MA In 2012, Hologic was growing significantly in its diagnostics offerings. But the Marlborough, MA-based company needed a bit more. The firm remedied this situation by making a move to acquire Gen-Probe for $3.

The diagnostics space is rapidly changing and growing. In May,a sessionon Center Stage at MDM East will address some of these changes in the in vitro diagnostics market along with fast growth markets and disruptive trends. We haveidentified

Roche has agreed to acquire Spark Therapeutics for $4.8 billion cash, Spark said today, in a deal designed to expand the biopharma giant into gene therapy with the marketed Luxturna (voretigene neparvovec-rzyl) and a pipeline of other gene t

Brigham and Womens Hospital investigators are working on a test that could either diagnose or predict Alzheimers disease before symptoms appear. The investigators approach is in the December issue of Alzheimers Dementia. Tau proteins have lo

The kilogram, kg, ampere, A, kelvin, K, and mole, mol, will have new definitions, but they will be so chosen that at the moment of change the magnitudes of the new units will be indistinguishable from those of the old units. The new definit

An estimated 100 million-plus people , roughly one-third of the U.S. population, will have had their DNA analyzed using an at-home genetic test kit by 2021. Up to 60% of the time, identified genetic variants are going to be proven correct wi

When it comes toin vitrodiagnostic (IVD) technologies, medical device and diagnostic companies have been chomping at the bit to produce the next big innovation. The last few years have seen a surge in IVD technologies in the market, as devic

Early treatment ofautism spectrum disorder(ASD) can significantly improve the lives of affected children and their families, but diagnosing the disorder is often a challenge. A company in Syracuse, NY hasdeveloped an epigenetic test that cou